Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Molecular Partners AG ADR
MOLNCurrent price
5.25 USD
-0.07 USD (-1.32%)
Last closed
5.51 USD
Company
www.molecularpartners.com
ISIN
US60853G1067
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
232 953 216 USD
Yield for 12 month
+18.78 %
1Y
3Y
5Y
10Y
15Y
MOLN
Molecular Partners AG, a clinical-stage biotechnology company, develops designed ankyrin repeat proteins therapeutics for the treatment of oncology and virology diseases in Switzerland. The company develops MP0317, a CD40 agonist designed to activate immune cells within the tumor microenvironment by anchoring to fibroblast activation protein that is in Phase I clinical trial; and MP0533, a novel tetra-specific T cell-engaging DARPin for acute myeloid leukemia. It also develops Switch-DARPin platform, a multispecific cKIT x CD16a x CD47 Switch-DARPin program for targeted and conditional immune cell activation; and Radio-DARPin Therapy (RDT) platform, a delivery system for effective and selective delivery of radioactive payloads to solid tumors. It has license and research collaboration agreements with Novartis Pharma AG to develop DARPin-conjugated radioligand therapies; and collaboration agreement with Orano Med SAS to develop novel Radio-DARPin therapeutics. Molecular Partners AG was incorporated in 2004 and is headquartered in Schlieren, Switzerland. Address: Wagistrasse 14, Schlieren, Switzerland, 8952
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
13.52 USDP/E ratio
–Dividend Yield
–Current Year
+7 991 643 USD
Last Year
+215 240 669 USD
Current Quarter
+1 761 159 USD
Last Quarter
+3 108 997 USD
Current Year
-46 335 177 USD
Last Year
+157 615 225 USD
Current Quarter
-13 099 118 USD
Last Quarter
-12 906 083 USD
Key Figures MOLN
1 year
3 years
5 years
10 years
EBITDA
-62 162 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-21.17 %
PEG Ratio
–
Return On Equity TTM
-37.37 %
Wall Street Target Price
13.52 USD
Revenue TTM
6 002 000 USD
Book Value
4.18 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
-73.2 %
Dividend Yield
–
Gross Profit TTM
138 851 000 USD
Earnings per share
-2.16 USD
Diluted Eps TTM
-2.16 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics MOLN
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History MOLN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation MOLN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
1.7775
Enterprise Value Revenue
10.4081
Price Sales TTM
38.8126
Enterprise Value EBITDA
1.2347
Price Book MRQ
1.4413
Financials MOLN
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators MOLN
For 52 weeks
3.32 USD
12.7 USD
50 Day MA
5.39 USD
Shares Short Prior Month
31 147
200 Day MA
5.15 USD
Short Ratio
4.5
Shares Short
33 492
Short Percent
0.15 %
BeatStart